By contrast, p‐TFCP2L1 and CDK1 were expressed in 92.8 and 93.0% of the bladder tumor samples, respectively (Fig 3B), with a wide range of H‐scores (0.0–231.0 with a median of 87.7 for p‐TFCP2L1, and 0.0–291.0 with a median of 100.0 for CDK1; Fig 3C). This evidence concerns the gene TFCP2L1 and urinary bladder neoplasm.